Stifel Maintains Hold on Ventyx Biosciences, Lowers Price Target to $2
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Alex Thompson has maintained a Hold rating on Ventyx Biosciences (NASDAQ:VTYX) but has reduced the price target from $6 to $2.
December 18, 2023 | 3:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst Alex Thompson maintains a Hold rating on Ventyx Biosciences and lowers the price target from $6 to $2.
The reduction in price target by a significant amount from $6 to $2 by a reputable analyst could lead to a negative sentiment among investors, potentially causing a short-term decline in Ventyx Biosciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100